DK555089A - Farmaceutiske praeparater indeholdende n-(3,4-dimethoxycinnamoyl)anthranilsyre - Google Patents

Farmaceutiske praeparater indeholdende n-(3,4-dimethoxycinnamoyl)anthranilsyre

Info

Publication number
DK555089A
DK555089A DK555089A DK555089A DK555089A DK 555089 A DK555089 A DK 555089A DK 555089 A DK555089 A DK 555089A DK 555089 A DK555089 A DK 555089A DK 555089 A DK555089 A DK 555089A
Authority
DK
Denmark
Prior art keywords
dimethoxycinnamoyl
composition
pharmaceutical preparations
preparations containing
anthranic acid
Prior art date
Application number
DK555089A
Other languages
Danish (da)
English (en)
Other versions
DK555089D0 (da
Inventor
Tokihiko Yamamoto
Taihei Shibazaki
Yukiyoshi Ajisawa
Ryoji Yamamoto
Yukihiko Kinoshita
Original Assignee
Kissei Pharmaceutical
Nitten Ophtalmic Res Inst Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13861211&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK555089(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kissei Pharmaceutical, Nitten Ophtalmic Res Inst Co filed Critical Kissei Pharmaceutical
Publication of DK555089D0 publication Critical patent/DK555089D0/da
Publication of DK555089A publication Critical patent/DK555089A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK555089A 1989-04-04 1989-11-07 Farmaceutiske praeparater indeholdende n-(3,4-dimethoxycinnamoyl)anthranilsyre DK555089A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1085521A JPH07116029B2 (ja) 1989-04-04 1989-04-04 トラニラスト水溶液製剤

Publications (2)

Publication Number Publication Date
DK555089D0 DK555089D0 (da) 1989-11-07
DK555089A true DK555089A (da) 1990-10-05

Family

ID=13861211

Family Applications (1)

Application Number Title Priority Date Filing Date
DK555089A DK555089A (da) 1989-04-04 1989-11-07 Farmaceutiske praeparater indeholdende n-(3,4-dimethoxycinnamoyl)anthranilsyre

Country Status (13)

Country Link
US (1) US5356620A (ko)
EP (1) EP0391002B1 (ko)
JP (1) JPH07116029B2 (ko)
KR (1) KR940002660B1 (ko)
AT (1) ATE103808T1 (ko)
AU (1) AU623191B2 (ko)
CA (1) CA2003190C (ko)
DE (1) DE68914438T2 (ko)
DK (1) DK555089A (ko)
ES (1) ES2063146T3 (ko)
FI (1) FI95773C (ko)
HK (1) HK1003780A1 (ko)
NO (1) NO176346C (ko)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5897858A (en) 1994-02-03 1999-04-27 Schering-Plough Healthcare Products, Inc. Nasal spray compositions exhibiting increased retention in the nasal cavity
EP0974350B1 (en) * 1996-02-07 2002-08-28 Lead Chemical Company Ltd. External preparation containing tranilast and process for producing the same
JPH09278653A (ja) * 1996-04-05 1997-10-28 Santen Pharmaceut Co Ltd 網膜疾患治療剤
IL118657A0 (en) * 1996-06-14 1996-10-16 Arad Dorit Inhibitors for picornavirus proteases
KR100509421B1 (ko) * 1996-09-28 2005-08-22 깃세이 야쿠힌 고교 가부시키가이샤 각막 상피하 혼탁 억제제
AU745028B2 (en) * 1996-10-14 2002-03-07 Kissei Pharmaceutical Co. Ltd. Secondary cataract inhibitor
DE69814612T2 (de) * 1997-02-14 2004-03-11 Kissei Pharmaceutical Co., Ltd., Matsumoto Stoffe zur hemmung der bildung des pterygiums und seines postoperative wiederauftretens
CA2286120A1 (en) * 1997-04-18 1998-10-29 Kissei Pharmaceutical Co., Ltd. Preventives or remedies for diseases affecting excessive proliferation of retinal pigment epithelial cells
IL122591A0 (en) 1997-12-14 1998-06-15 Arad Dorit Pharmaceutical compositions comprising cystein protease inhibitors
US6274626B1 (en) 1998-12-22 2001-08-14 Bausch & Lomb Incorporated Pheniramine-containing compositions and method for treating allergic responses
JP2001158750A (ja) * 1999-12-02 2001-06-12 Lion Corp 眼科用組成物及び抗アレルギー薬の持続性向上方法
JP4541504B2 (ja) * 2000-06-14 2010-09-08 沢井製薬株式会社 トラニラストまたはその薬理学的に許容される塩を有効成分として含有する安定な水溶液製剤
WO2002055454A2 (en) * 2001-01-10 2002-07-18 Smithkline Beecham Corporation Process and product
JP2011225626A (ja) * 2001-02-01 2011-11-10 Rohto Pharmaceutical Co Ltd 点眼剤
JP2002363075A (ja) * 2001-06-05 2002-12-18 Kao Corp 高血圧症予防・治療剤
DE10254872A1 (de) * 2002-11-25 2004-06-03 Symrise Gmbh & Co. Kg Anthranilsäureamide und deren Derivate als kosmetische und pharmazeutische Wirkstoffe
JP2004189731A (ja) * 2002-11-26 2004-07-08 Taisho Pharmaceut Co Ltd 点鼻剤
US20050106230A1 (en) * 2003-11-17 2005-05-19 Young Janel E. Drug-enhanced adhesion prevention
JP2006306765A (ja) * 2005-04-27 2006-11-09 Nippon Tenganyaku Kenkyusho:Kk トラニラスト水性点眼液
DK2799427T3 (en) 2006-07-05 2018-10-22 Fibrotech Therapeutics Pty Ltd Therapeutic compounds
KR20160017139A (ko) * 2007-12-21 2016-02-15 피브로테크 세라퓨틱 피티와이 엘티디 항섬유증 제제의 할로겐화 유사체
EP2947073B1 (en) 2009-10-22 2019-04-03 Fibrotech Therapeutics Pty Ltd Fused ring analogues of anti-fibrotic agents
JP2013535451A (ja) * 2010-07-21 2013-09-12 アルコン リサーチ， リミテッド 増強された溶解度特徴を有する薬学的組成物
JP7191515B2 (ja) * 2017-01-17 2022-12-19 ロート製薬株式会社 眼科組成物
KR20190115451A (ko) 2017-02-03 2019-10-11 세르타 테라퓨틱스 피티와이 엘티디. 항-섬유성 화합물
JP6427244B2 (ja) * 2017-10-03 2018-11-21 ロート製薬株式会社 点眼剤
TWI651095B (zh) * 2017-10-18 2019-02-21 晶碩光學股份有限公司 具有抗敏舒緩效果的眼用產品
CN109718376B (zh) * 2017-10-27 2022-01-25 晶硕光学股份有限公司 具有抗敏舒缓效果的眼用产品
CN112236413A (zh) * 2018-08-14 2021-01-15 努福米克斯技术有限公司 结晶曲尼司特盐及其药物用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1296518A (fr) * 1959-04-25 1962-06-22 Véhicule liquide pour collyre
US3856919A (en) * 1970-06-08 1974-12-24 Burton Parsons Chemicals Inc Ophthalmic solution
US4070484A (en) * 1973-01-18 1978-01-24 Kissei Pharmaceutical Co., Ltd. Antiallergic composition containing aromatic carboxylic amide derivatives and method of using the same
US4029817A (en) * 1973-09-24 1977-06-14 Allergan Pharmaceuticals Soft contact lens preserving solutions
JPS6144811A (ja) * 1984-08-10 1986-03-04 Ss Pharmaceut Co Ltd 徐放性ジクロフエナクナトリウム製剤
US4666929A (en) * 1985-04-10 1987-05-19 Shiseido Company Ltd. Anthranilic acid ester derivatives and antiinflammatory and analgetic external preparations containing the same
CA1291036C (en) * 1986-04-23 1991-10-22 Edwin I. Stoltz Nasal administration of drugs
KR910002669B1 (ko) * 1986-12-25 1991-05-03 데이산세이야꾸 가부시끼가이샤 서방성 과립 및 그를 함유하는 지속성 복합과립
JPH01294620A (ja) * 1988-05-19 1989-11-28 Kissei Pharmaceut Co Ltd 水溶液製剤およびその製造方法

Also Published As

Publication number Publication date
JPH07116029B2 (ja) 1995-12-13
NO894602L (no) 1990-10-05
CA2003190A1 (en) 1990-10-04
US5356620A (en) 1994-10-18
CA2003190C (en) 1997-04-29
FI95773B (fi) 1995-12-15
EP0391002B1 (en) 1994-04-06
AU623191B2 (en) 1992-05-07
HK1003780A1 (en) 1998-11-06
EP0391002A2 (en) 1990-10-10
KR900015722A (ko) 1990-11-10
EP0391002A3 (en) 1991-06-26
FI895492A0 (fi) 1989-11-17
KR940002660B1 (ko) 1994-03-28
NO176346C (no) 1995-03-22
DE68914438D1 (de) 1994-05-11
NO176346B (no) 1994-12-12
ATE103808T1 (de) 1994-04-15
DE68914438T2 (de) 1994-07-28
DK555089D0 (da) 1989-11-07
NO894602D0 (no) 1989-11-17
FI95773C (fi) 1996-03-25
AU4438489A (en) 1990-10-11
ES2063146T3 (es) 1995-01-01
JPH02264716A (ja) 1990-10-29

Similar Documents

Publication Publication Date Title
DK555089D0 (da) Farmaceutiske praeparater indeholdende n-(3,4-dimethoxycinnamoyl)anthranilsyre
FI901421A0 (fi) N-(3-hydroxi-4-piperidinyl) (dihydrobenzofuran, dihydro-2h-benzopyran- eller dihydrobenzodioxin) karboxiamidderivat.
MC2195A1 (fr) Derives d'acides amines
BR0213242A (pt) Composto ou um seu sal ou solvato, composto e seus sais de adição de ácido fisiologicamente aceitáveis, composição farmacêutica, método de tratamento de um ou mais distúrbios, uso de um composto, e, processo de preparação de um composto
ATE104971T1 (de) 2-aminopyrimidinon-derivate.
DK529888D0 (da) Substituerede n-(1-alkyl-3-hydroxy-4-piperidinyl) benzamider
DE3778642D1 (de) Therapeutikum zur behandlung von magengeschwueren.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment